These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2989001)

  • 1. Synthesis and release of plasminogen activator by lymphoid cell lines of malignant origin and its effect on lymphocyte cytotoxicity.
    Sundar SK; Bergeron J; Menezes J
    Exp Biol; 1985; 43(4):277-85. PubMed ID: 2989001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purified plasminogen activating factor produced by malignant lymphoid cells abrogates lymphocyte cytotoxicity.
    Sundar SK; Bergeron J; Menezes J
    Clin Exp Immunol; 1984 Jun; 56(3):701-8. PubMed ID: 6430612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of plasminogen activator and inhibition of embryonic cell aggregation by cultured human normal and neoplastic cells.
    Phan Thu A; Popovic M
    Neoplasma; 1979; 26(6):663-75. PubMed ID: 575560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic cytotoxicity against autologous human lymphocytes transformed or infected by Epstein-Bar virus: role of antibody-dependent cellular cytotoxicity in health individuals.
    Aya T; Mizuno F; Osato T
    J Natl Cancer Inst; 1980 Aug; 65(2):265-71. PubMed ID: 6249949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human hepatoma cell line plasminogen activator.
    Levin EG; Fair DS; Loskutoff DJ
    J Lab Clin Med; 1983 Oct; 102(4):500-8. PubMed ID: 6311924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. I. The effect of lectin on the proliferative frequency and cytotoxic activity of cultured lymphoid cells.
    Vose BM; Bonnard GD
    J Immunol; 1983 Feb; 130(2):687-93. PubMed ID: 6600251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of cellular immune response to EBV by using cloned T cell lines.
    Slovin SF; Schooley RT; Thorley-Lawson DA
    J Immunol; 1983 May; 130(5):2127-32. PubMed ID: 6187840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-6 induces target cell resistance to HIV-specific cytotoxic lysis.
    Liu M; Martinez-Maza O; Johnson MT; Fan J; Kishimoto T; Plaeger S
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Aug; 9(4):321-31. PubMed ID: 7600099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional CD4(+) and CD8(+) T-cell responses induced by autologous mitomycin C treated Epstein-Barr virus transformed lymphoblastoid cell lines.
    Meij P; Bloemena E; Palmen N; Brink A; Vervoort MB; Meijer CJ; Middeldorp JM
    Cell Immunol; 2001 Feb; 208(1):25-33. PubMed ID: 11277616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.
    Collen D; De Cock F; Demarsin E; Lijnen HR; Stump DC
    Thromb Haemost; 1986 Aug; 56(1):35-9. PubMed ID: 3095946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cultured human mesangial cells produce both type 1 and type 2 plasminogen activator inhibitors.
    Colucci M; Gesualdo L; Montemurro P; Cavallo LG; Conese M; Mascolo E; Ranieri E; Di Paolo S; Schena FP; Semeraro N
    Thromb Haemost; 1995 Dec; 74(6):1516-20. PubMed ID: 8772230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human tumor cell-associated fibrinolysis by vascular bovine smooth muscle cells.
    Laug WE
    J Natl Cancer Inst; 1985 Aug; 75(2):345-52. PubMed ID: 3860687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T lymphocyte culture established by repeated stimulation with the autologous lymphoblastoid line. MHC class II restricted interactions with B blasts.
    Torsteinsdottir S; Masucci MG; Szigeti R; Bishara A; Brautbar C; Klein G; Klein E
    Mol Biol Med; 1984 Aug; 2(4):285-99. PubMed ID: 6443579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-specific cytotoxic T cell clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin complementary DNA.
    Jerome KR; Domenech N; Finn OJ
    J Immunol; 1993 Aug; 151(3):1654-62. PubMed ID: 8393050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity of autologous Epstein-Barr virus-transformed cells mediated by interleukin-2 dependent, long-term T cell cultures is augmented by beta, but not alpha, recombinant interferon.
    Chen BP; Sondel PM
    J Biol Response Mod; 1986 Aug; 5(4):351-61. PubMed ID: 3016203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of long-term human cytolytic cell lines with persistent natural killer activity.
    Krensky AM; Ault KA; Reiss CS; Strominger JL; Burakoff SJ
    J Immunol; 1982 Oct; 129(4):1748-51. PubMed ID: 6286775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA.
    Colucci M; D'Aprile AM; Italia A; Gresele P; Morser J; Semeraro N
    Thromb Haemost; 2001 Apr; 85(4):661-6. PubMed ID: 11341502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes.
    Comoli P; Pedrazzoli P; Maccario R; Basso S; Carminati O; Labirio M; Schiavo R; Secondino S; Frasson C; Perotti C; Moroni M; Locatelli F; Siena S
    J Clin Oncol; 2005 Dec; 23(35):8942-9. PubMed ID: 16204009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T lymphocyte-mediated cytotoxicity against autologous EBV-genome-bearing B cells.
    Tsoukas CD; Fox RI; Slovin SF; Carson DA; Pellegrino M; Fong S; Pasquali JL; Ferrone S; Kung P; Vaughan JH
    J Immunol; 1981 May; 126(5):1742-6. PubMed ID: 6163816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-13 gene expression by malignant and EBV-transformed human B lymphocytes.
    Fior R; Vita N; Raphael M; Minty A; Maillot MC; Crevon MC; Caput D; Biberfeld P; Ferrara P; Galanaud P
    Eur Cytokine Netw; 1994; 5(6):593-600. PubMed ID: 7727691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.